Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Crohn Disease | 75 | 2024 | 2286 | 5.570 |
Why?
|
Colitis, Ulcerative | 56 | 2024 | 1920 | 4.510 |
Why?
|
Inflammatory Bowel Diseases | 57 | 2024 | 2429 | 4.240 |
Why?
|
Immunosuppressive Agents | 25 | 2022 | 4215 | 1.770 |
Why?
|
Gastrointestinal Agents | 12 | 2024 | 511 | 1.500 |
Why?
|
Immunologic Factors | 13 | 2023 | 1594 | 1.360 |
Why?
|
Tacrolimus | 8 | 2023 | 753 | 1.080 |
Why?
|
Child | 142 | 2024 | 80670 | 1.010 |
Why?
|
Azathioprine | 8 | 2022 | 354 | 0.910 |
Why?
|
Proctocolectomy, Restorative | 3 | 2023 | 191 | 0.880 |
Why?
|
Helicobacter pylori | 2 | 2023 | 380 | 0.840 |
Why?
|
Methotrexate | 4 | 2024 | 1719 | 0.830 |
Why?
|
Helicobacter Infections | 2 | 2023 | 390 | 0.830 |
Why?
|
Anti-Inflammatory Agents | 13 | 2019 | 1805 | 0.770 |
Why?
|
Ileum | 6 | 2023 | 558 | 0.750 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2022 | 388 | 0.680 |
Why?
|
Adolescent | 103 | 2024 | 88902 | 0.670 |
Why?
|
Adrenal Cortex Hormones | 17 | 2019 | 1884 | 0.660 |
Why?
|
Gastroenterology | 7 | 2018 | 593 | 0.620 |
Why?
|
Erythrocyte Indices | 1 | 2019 | 143 | 0.620 |
Why?
|
Metronidazole | 4 | 2023 | 237 | 0.620 |
Why?
|
Electric Power Supplies | 1 | 2018 | 94 | 0.570 |
Why?
|
Thalidomide | 4 | 2016 | 886 | 0.570 |
Why?
|
Antibodies, Monoclonal | 14 | 2023 | 9244 | 0.540 |
Why?
|
Tumor Necrosis Factor-alpha | 9 | 2024 | 4349 | 0.510 |
Why?
|
Lymphoma | 4 | 2013 | 1899 | 0.470 |
Why?
|
Hereditary Angioedema Types I and II | 1 | 2014 | 10 | 0.460 |
Why?
|
Lactobacillus | 3 | 2024 | 212 | 0.450 |
Why?
|
Mesalamine | 7 | 2022 | 133 | 0.440 |
Why?
|
Metagenome | 3 | 2012 | 464 | 0.440 |
Why?
|
Intestines | 6 | 2022 | 1904 | 0.440 |
Why?
|
Immunocompromised Host | 4 | 2014 | 865 | 0.440 |
Why?
|
Digestive System Surgical Procedures | 3 | 2014 | 584 | 0.430 |
Why?
|
Bacteroidetes | 1 | 2013 | 84 | 0.420 |
Why?
|
Gastrointestinal Diseases | 3 | 2014 | 1203 | 0.420 |
Why?
|
Intestinal Mucosa | 10 | 2020 | 3041 | 0.420 |
Why?
|
Humans | 179 | 2024 | 766812 | 0.420 |
Why?
|
Registries | 13 | 2024 | 8352 | 0.410 |
Why?
|
Colon | 12 | 2020 | 1797 | 0.410 |
Why?
|
Child, Preschool | 53 | 2024 | 42577 | 0.410 |
Why?
|
Enterotoxins | 1 | 2013 | 366 | 0.380 |
Why?
|
Biological Therapy | 1 | 2013 | 140 | 0.380 |
Why?
|
Child Welfare | 2 | 2014 | 521 | 0.370 |
Why?
|
Hospitals, Pediatric | 2 | 2018 | 1851 | 0.370 |
Why?
|
Abdominal Pain | 6 | 2014 | 1069 | 0.360 |
Why?
|
Chickenpox Vaccine | 1 | 2010 | 39 | 0.350 |
Why?
|
Vaccination | 8 | 2024 | 3435 | 0.340 |
Why?
|
Esophagitis | 4 | 2023 | 164 | 0.340 |
Why?
|
Biological Products | 3 | 2019 | 948 | 0.330 |
Why?
|
Genes, Bacterial | 1 | 2013 | 1076 | 0.330 |
Why?
|
Antibodies | 3 | 2023 | 2421 | 0.330 |
Why?
|
Chickenpox | 1 | 2010 | 95 | 0.330 |
Why?
|
Male | 110 | 2024 | 364154 | 0.330 |
Why?
|
Female | 115 | 2024 | 396532 | 0.330 |
Why?
|
Nutritional Status | 3 | 2014 | 1621 | 0.330 |
Why?
|
Child Nutrition Disorders | 2 | 2008 | 139 | 0.320 |
Why?
|
Mouth | 1 | 2011 | 383 | 0.310 |
Why?
|
Influenza B virus | 1 | 2009 | 53 | 0.310 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2009 | 85 | 0.310 |
Why?
|
Drug Therapy, Combination | 9 | 2024 | 6306 | 0.310 |
Why?
|
Remission Induction | 11 | 2019 | 2413 | 0.300 |
Why?
|
Immunity, Cellular | 2 | 2020 | 1560 | 0.300 |
Why?
|
Tongue | 1 | 2011 | 406 | 0.300 |
Why?
|
Colitis | 5 | 2017 | 1238 | 0.300 |
Why?
|
Diarrhea | 2 | 2013 | 1317 | 0.300 |
Why?
|
Young Adult | 29 | 2024 | 59939 | 0.300 |
Why?
|
Treatment Outcome | 37 | 2024 | 65286 | 0.290 |
Why?
|
Bacterial Toxins | 1 | 2013 | 922 | 0.290 |
Why?
|
Azithromycin | 2 | 2019 | 201 | 0.280 |
Why?
|
Growth Disorders | 3 | 2009 | 634 | 0.280 |
Why?
|
Endoscopy | 2 | 2017 | 1854 | 0.280 |
Why?
|
Receptors, Interleukin-10 | 2 | 2017 | 49 | 0.280 |
Why?
|
Severity of Illness Index | 25 | 2022 | 15912 | 0.270 |
Why?
|
Probiotics | 3 | 2006 | 387 | 0.270 |
Why?
|
Depression | 10 | 2016 | 8225 | 0.270 |
Why?
|
Family Leave | 1 | 2006 | 18 | 0.270 |
Why?
|
Anxiety | 4 | 2018 | 4668 | 0.270 |
Why?
|
Clostridium Infections | 1 | 2013 | 563 | 0.270 |
Why?
|
Child Advocacy | 1 | 2006 | 48 | 0.270 |
Why?
|
Clarithromycin | 2 | 2023 | 87 | 0.260 |
Why?
|
Social Security | 1 | 2006 | 101 | 0.260 |
Why?
|
Endoscopy, Gastrointestinal | 4 | 2023 | 889 | 0.260 |
Why?
|
Adaptive Immunity | 1 | 2010 | 734 | 0.250 |
Why?
|
Anti-Bacterial Agents | 10 | 2024 | 7475 | 0.240 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 453 | 0.240 |
Why?
|
Postoperative Complications | 2 | 2017 | 15831 | 0.230 |
Why?
|
Drug Resistance | 1 | 2010 | 1592 | 0.230 |
Why?
|
Prospective Studies | 33 | 2024 | 54872 | 0.230 |
Why?
|
Age of Onset | 5 | 2024 | 3343 | 0.220 |
Why?
|
Patient Advocacy | 1 | 2006 | 361 | 0.220 |
Why?
|
Immunity, Humoral | 3 | 2024 | 609 | 0.220 |
Why?
|
Bacteria | 2 | 2012 | 2212 | 0.220 |
Why?
|
Agar | 1 | 2023 | 51 | 0.220 |
Why?
|
Eating | 4 | 2018 | 1539 | 0.210 |
Why?
|
Societies, Medical | 3 | 2014 | 3957 | 0.210 |
Why?
|
Sulfasalazine | 1 | 2022 | 85 | 0.200 |
Why?
|
RNA, Ribosomal, 16S | 4 | 2019 | 1044 | 0.200 |
Why?
|
Amoxicillin | 1 | 2023 | 179 | 0.200 |
Why?
|
Education, Medical, Continuing | 2 | 2018 | 830 | 0.200 |
Why?
|
Psychotherapy | 3 | 2016 | 1648 | 0.200 |
Why?
|
Follow-Up Studies | 21 | 2024 | 39312 | 0.200 |
Why?
|
Homocysteine | 1 | 2005 | 638 | 0.190 |
Why?
|
Adult | 47 | 2024 | 223305 | 0.190 |
Why?
|
Pancytopenia | 1 | 2002 | 102 | 0.190 |
Why?
|
Interleukin-10 | 2 | 2017 | 1182 | 0.190 |
Why?
|
Intestinal Perforation | 2 | 2014 | 254 | 0.190 |
Why?
|
Influenza Vaccines | 1 | 2009 | 780 | 0.190 |
Why?
|
Methyltransferases | 2 | 2009 | 373 | 0.180 |
Why?
|
Depressive Disorder | 4 | 2015 | 3715 | 0.180 |
Why?
|
Vaccines | 1 | 2009 | 842 | 0.180 |
Why?
|
Anal Canal | 1 | 2023 | 375 | 0.180 |
Why?
|
Malabsorption Syndromes | 2 | 2015 | 135 | 0.180 |
Why?
|
Endothelial Growth Factors | 2 | 2001 | 671 | 0.170 |
Why?
|
Hepatocyte Growth Factor | 1 | 2001 | 268 | 0.170 |
Why?
|
Retrospective Studies | 25 | 2023 | 81657 | 0.170 |
Why?
|
Bacterial Proteins | 1 | 2013 | 3833 | 0.170 |
Why?
|
Colonoscopy | 5 | 2022 | 1409 | 0.170 |
Why?
|
Microbial Sensitivity Tests | 2 | 2023 | 1972 | 0.170 |
Why?
|
Anastomosis, Surgical | 1 | 2023 | 992 | 0.170 |
Why?
|
Immunity, Innate | 2 | 2016 | 3079 | 0.170 |
Why?
|
Propranolol | 1 | 2001 | 493 | 0.170 |
Why?
|
Lymphokines | 2 | 2001 | 924 | 0.170 |
Why?
|
Foreign Bodies | 2 | 2015 | 403 | 0.160 |
Why?
|
Ileitis | 1 | 2019 | 40 | 0.160 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 5 | 2014 | 2270 | 0.160 |
Why?
|
Biomedical Research | 3 | 2019 | 3459 | 0.160 |
Why?
|
Drug Resistance, Bacterial | 2 | 2023 | 1065 | 0.160 |
Why?
|
Case-Control Studies | 11 | 2020 | 22248 | 0.160 |
Why?
|
Parvoviridae Infections | 1 | 1998 | 39 | 0.160 |
Why?
|
Osteoporosis | 1 | 2008 | 1581 | 0.160 |
Why?
|
Parvovirus B19, Human | 1 | 1998 | 42 | 0.160 |
Why?
|
Anemia | 1 | 2008 | 1514 | 0.160 |
Why?
|
Vitamin A Deficiency | 2 | 2001 | 88 | 0.160 |
Why?
|
Hospital Departments | 1 | 2018 | 134 | 0.150 |
Why?
|
Infant | 18 | 2024 | 36459 | 0.150 |
Why?
|
Vitamin E Deficiency | 1 | 1998 | 30 | 0.150 |
Why?
|
Hepatitis, Viral, Human | 1 | 1998 | 141 | 0.150 |
Why?
|
Antibodies, Viral | 3 | 2024 | 3213 | 0.150 |
Why?
|
Metabolic Clearance Rate | 1 | 2018 | 361 | 0.150 |
Why?
|
Complementary Therapies | 1 | 2002 | 486 | 0.150 |
Why?
|
Clinical Trials as Topic | 4 | 2019 | 8045 | 0.140 |
Why?
|
Ileus | 1 | 2017 | 65 | 0.140 |
Why?
|
Surgical Stomas | 1 | 2017 | 45 | 0.140 |
Why?
|
Influenza, Human | 1 | 2009 | 1543 | 0.140 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2001 | 245 | 0.140 |
Why?
|
Ileostomy | 1 | 2017 | 122 | 0.140 |
Why?
|
Immunotoxins | 1 | 1997 | 175 | 0.140 |
Why?
|
Colonic Pouches | 2 | 2009 | 122 | 0.140 |
Why?
|
Play and Playthings | 1 | 2017 | 85 | 0.130 |
Why?
|
Oral Ulcer | 1 | 2017 | 95 | 0.130 |
Why?
|
Diphtheria Toxin | 1 | 1997 | 253 | 0.130 |
Why?
|
Neurofibromatosis 1 | 1 | 2001 | 561 | 0.130 |
Why?
|
Inservice Training | 1 | 2018 | 374 | 0.130 |
Why?
|
Transcription Factor RelA | 1 | 2017 | 252 | 0.130 |
Why?
|
Inappropriate Prescribing | 1 | 2018 | 212 | 0.130 |
Why?
|
Skin Ulcer | 1 | 2017 | 131 | 0.130 |
Why?
|
Prognosis | 10 | 2019 | 29959 | 0.130 |
Why?
|
Inflammation | 6 | 2019 | 10863 | 0.130 |
Why?
|
Lung Diseases, Fungal | 1 | 2016 | 123 | 0.130 |
Why?
|
Myositis | 1 | 1998 | 268 | 0.130 |
Why?
|
Osteomyelitis | 1 | 1999 | 408 | 0.130 |
Why?
|
Lymphocytes | 1 | 2003 | 2606 | 0.120 |
Why?
|
Immunophenotyping | 1 | 2020 | 1867 | 0.120 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7430 | 0.120 |
Why?
|
Haploinsufficiency | 1 | 2017 | 334 | 0.120 |
Why?
|
Duodenum | 2 | 2015 | 495 | 0.120 |
Why?
|
Insurance Coverage | 1 | 2006 | 1945 | 0.120 |
Why?
|
Feces | 3 | 2024 | 1505 | 0.120 |
Why?
|
Receptors, Interleukin-2 | 1 | 1996 | 565 | 0.120 |
Why?
|
Lactase | 1 | 2015 | 72 | 0.120 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1997 | 590 | 0.120 |
Why?
|
Enteral Nutrition | 4 | 2009 | 802 | 0.120 |
Why?
|
Microvilli | 1 | 2015 | 234 | 0.120 |
Why?
|
Genes, Dominant | 1 | 2017 | 855 | 0.120 |
Why?
|
Observer Variation | 2 | 2018 | 2614 | 0.120 |
Why?
|
Colic | 1 | 2014 | 42 | 0.110 |
Why?
|
Nausea | 2 | 2014 | 681 | 0.110 |
Why?
|
Mucolipidoses | 1 | 2015 | 82 | 0.110 |
Why?
|
Odds Ratio | 5 | 2022 | 9661 | 0.110 |
Why?
|
Laparoscopy | 2 | 2016 | 2038 | 0.110 |
Why?
|
Prednisone | 3 | 2014 | 1566 | 0.110 |
Why?
|
Intestinal Obstruction | 1 | 2017 | 433 | 0.110 |
Why?
|
Disease Progression | 5 | 2018 | 13642 | 0.110 |
Why?
|
Gastrointestinal Tract | 2 | 2012 | 835 | 0.110 |
Why?
|
Autistic Disorder | 1 | 2023 | 1238 | 0.110 |
Why?
|
Biopsy | 5 | 2019 | 6779 | 0.110 |
Why?
|
Pediatrics | 3 | 2017 | 3614 | 0.110 |
Why?
|
Certification | 1 | 2017 | 420 | 0.110 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 1997 | 646 | 0.110 |
Why?
|
Intestinal Fistula | 1 | 2014 | 146 | 0.110 |
Why?
|
Constipation | 1 | 2018 | 568 | 0.110 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 26309 | 0.110 |
Why?
|
Health Resources | 1 | 2019 | 950 | 0.100 |
Why?
|
Blood Sedimentation | 4 | 2014 | 234 | 0.100 |
Why?
|
Laparotomy | 1 | 2015 | 459 | 0.100 |
Why?
|
Reproducibility of Results | 8 | 2022 | 20146 | 0.100 |
Why?
|
Intestine, Small | 1 | 2018 | 1217 | 0.100 |
Why?
|
Gene Expression Profiling | 3 | 2019 | 9528 | 0.100 |
Why?
|
Body Mass Index | 3 | 2024 | 13050 | 0.100 |
Why?
|
Bacteroides fragilis | 1 | 2013 | 250 | 0.100 |
Why?
|
Endpoint Determination | 2 | 2005 | 592 | 0.100 |
Why?
|
Intestinal Diseases | 1 | 1996 | 506 | 0.100 |
Why?
|
Budesonide | 1 | 2012 | 162 | 0.090 |
Why?
|
Expert Testimony | 1 | 2013 | 266 | 0.090 |
Why?
|
Leukocytes | 1 | 2019 | 2034 | 0.090 |
Why?
|
Th17 Cells | 1 | 2017 | 790 | 0.090 |
Why?
|
United States | 13 | 2023 | 72945 | 0.090 |
Why?
|
Deglutition | 1 | 2012 | 208 | 0.090 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2023 | 3667 | 0.090 |
Why?
|
Erythema Nodosum | 1 | 2010 | 32 | 0.090 |
Why?
|
Interleukin-1beta | 1 | 2016 | 1026 | 0.090 |
Why?
|
Psychophysiologic Disorders | 1 | 2012 | 222 | 0.090 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2016 | 713 | 0.090 |
Why?
|
Interleukin-2 | 1 | 1997 | 1895 | 0.090 |
Why?
|
Nutritional Support | 2 | 2011 | 178 | 0.090 |
Why?
|
Information Systems | 1 | 2012 | 400 | 0.090 |
Why?
|
Stomatitis, Aphthous | 1 | 2010 | 51 | 0.090 |
Why?
|
Lung Diseases, Interstitial | 1 | 1998 | 940 | 0.080 |
Why?
|
Thromboembolism | 2 | 2013 | 1003 | 0.080 |
Why?
|
Microfilament Proteins | 1 | 2015 | 1130 | 0.080 |
Why?
|
Logistic Models | 4 | 2018 | 13276 | 0.080 |
Why?
|
Acute-Phase Proteins | 1 | 2010 | 251 | 0.080 |
Why?
|
Personality Inventory | 1 | 2012 | 1019 | 0.080 |
Why?
|
Multivariate Analysis | 4 | 2018 | 12064 | 0.080 |
Why?
|
Anus Diseases | 1 | 2009 | 53 | 0.080 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 3431 | 0.080 |
Why?
|
Prevalence | 6 | 2019 | 15835 | 0.080 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2001 | 748 | 0.080 |
Why?
|
Migraine Disorders | 1 | 2001 | 1710 | 0.080 |
Why?
|
Boston | 2 | 2018 | 9346 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2018 | 6066 | 0.080 |
Why?
|
Leukocyte L1 Antigen Complex | 2 | 2022 | 92 | 0.080 |
Why?
|
North America | 4 | 2017 | 1287 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2001 | 3803 | 0.070 |
Why?
|
Sleep | 2 | 2014 | 4814 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2018 | 2233 | 0.070 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2009 | 219 | 0.070 |
Why?
|
Nod2 Signaling Adaptor Protein | 1 | 2007 | 86 | 0.070 |
Why?
|
Interleukin-6 | 2 | 2001 | 3226 | 0.070 |
Why?
|
Internet | 2 | 2017 | 3113 | 0.070 |
Why?
|
Quality of Life | 4 | 2019 | 13476 | 0.070 |
Why?
|
Papillomaviridae | 1 | 2013 | 1139 | 0.070 |
Why?
|
Growth | 1 | 2009 | 365 | 0.070 |
Why?
|
Papillomavirus Vaccines | 1 | 2013 | 497 | 0.070 |
Why?
|
Child Behavior | 1 | 2012 | 864 | 0.070 |
Why?
|
Genetic Research | 1 | 2007 | 173 | 0.070 |
Why?
|
Information Storage and Retrieval | 1 | 2012 | 832 | 0.070 |
Why?
|
DNA, Bacterial | 1 | 2011 | 1477 | 0.070 |
Why?
|
Thioguanine | 1 | 2006 | 45 | 0.070 |
Why?
|
Receptors, Interleukin | 1 | 2007 | 243 | 0.070 |
Why?
|
Chronic Disease | 4 | 2017 | 9358 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 2018 | 1931 | 0.070 |
Why?
|
Arthralgia | 1 | 2010 | 459 | 0.070 |
Why?
|
Phenotype | 6 | 2022 | 16722 | 0.070 |
Why?
|
Capsule Endoscopy | 1 | 2007 | 107 | 0.070 |
Why?
|
Hematologic Tests | 1 | 2007 | 239 | 0.070 |
Why?
|
Research | 2 | 2006 | 1977 | 0.060 |
Why?
|
Wound Healing | 1 | 1997 | 2800 | 0.060 |
Why?
|
Recurrence | 4 | 2005 | 8507 | 0.060 |
Why?
|
Intestinal Absorption | 1 | 2006 | 400 | 0.060 |
Why?
|
Cell Adhesion | 2 | 2003 | 3093 | 0.060 |
Why?
|
Neoplasms | 1 | 2014 | 22350 | 0.060 |
Why?
|
Time Factors | 6 | 2017 | 40149 | 0.060 |
Why?
|
Nutrition Disorders | 1 | 2006 | 203 | 0.060 |
Why?
|
Physicians | 2 | 2021 | 4591 | 0.060 |
Why?
|
Antibodies, Fungal | 1 | 2004 | 33 | 0.060 |
Why?
|
Probability | 2 | 2018 | 2476 | 0.060 |
Why?
|
Antimetabolites | 1 | 2005 | 128 | 0.060 |
Why?
|
Analysis of Variance | 3 | 2012 | 6214 | 0.060 |
Why?
|
Vomiting | 1 | 2008 | 652 | 0.060 |
Why?
|
Porins | 1 | 2004 | 78 | 0.060 |
Why?
|
Bone Diseases, Metabolic | 1 | 2008 | 407 | 0.060 |
Why?
|
Reference Values | 3 | 2007 | 4914 | 0.060 |
Why?
|
Age Factors | 5 | 2022 | 18397 | 0.060 |
Why?
|
Self Report | 2 | 2016 | 3771 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 1996 | 2255 | 0.060 |
Why?
|
Risk | 2 | 2013 | 9602 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2017 | 3114 | 0.060 |
Why?
|
Information Dissemination | 1 | 2012 | 1142 | 0.060 |
Why?
|
Proteins | 1 | 1998 | 6002 | 0.050 |
Why?
|
New England | 2 | 2023 | 1058 | 0.050 |
Why?
|
Cohort Studies | 8 | 2022 | 41706 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3796 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 3230 | 0.050 |
Why?
|
Length of Stay | 1 | 2016 | 6491 | 0.050 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2004 | 297 | 0.050 |
Why?
|
Infant, Newborn | 5 | 2018 | 26387 | 0.050 |
Why?
|
Immunoglobulin G | 2 | 2024 | 4559 | 0.050 |
Why?
|
Risk Factors | 8 | 2022 | 74889 | 0.050 |
Why?
|
Peptides | 1 | 2014 | 4347 | 0.050 |
Why?
|
MEDLINE | 1 | 2001 | 119 | 0.050 |
Why?
|
Clinical Competence | 1 | 2017 | 4858 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11062 | 0.050 |
Why?
|
Drug Utilization | 1 | 2007 | 1188 | 0.050 |
Why?
|
Food, Formulated | 1 | 2001 | 103 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2013 | 1639 | 0.050 |
Why?
|
Placebos | 1 | 2005 | 1659 | 0.050 |
Why?
|
Patient Selection | 2 | 2019 | 4252 | 0.050 |
Why?
|
Neurofibroma | 1 | 2001 | 95 | 0.050 |
Why?
|
Immunoglobulin A | 1 | 2004 | 992 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8540 | 0.050 |
Why?
|
Double-Blind Method | 2 | 2024 | 12430 | 0.040 |
Why?
|
Emotions | 1 | 2012 | 2758 | 0.040 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2012 | 2809 | 0.040 |
Why?
|
Anticoagulants | 2 | 2013 | 4854 | 0.040 |
Why?
|
Algorithms | 4 | 2018 | 14073 | 0.040 |
Why?
|
Behcet Syndrome | 1 | 2001 | 86 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2005 | 14653 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2015 | 12795 | 0.040 |
Why?
|
Pulmonary Embolism | 1 | 2013 | 2596 | 0.040 |
Why?
|
Syndrome | 2 | 2008 | 3271 | 0.040 |
Why?
|
Pilot Projects | 2 | 2024 | 8728 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 1997 | 10263 | 0.040 |
Why?
|
Viral Load | 1 | 2009 | 3385 | 0.040 |
Why?
|
Thrombosis | 1 | 2013 | 2953 | 0.040 |
Why?
|
Incidence | 4 | 2013 | 21527 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2001 | 3511 | 0.040 |
Why?
|
Disability Evaluation | 1 | 2006 | 1828 | 0.040 |
Why?
|
Secondary Prevention | 1 | 2005 | 1469 | 0.040 |
Why?
|
Cryptogenic Organizing Pneumonia | 1 | 1998 | 28 | 0.040 |
Why?
|
Smoking | 2 | 2013 | 9077 | 0.040 |
Why?
|
Integrins | 1 | 2003 | 839 | 0.040 |
Why?
|
Regression Analysis | 4 | 2013 | 6329 | 0.040 |
Why?
|
Antibodies, Bacterial | 1 | 2004 | 1477 | 0.040 |
Why?
|
Micronutrients | 1 | 2001 | 390 | 0.040 |
Why?
|
Duodenal Diseases | 1 | 1998 | 101 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1614 | 0.040 |
Why?
|
Iron | 1 | 2006 | 1812 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2013 | 15425 | 0.040 |
Why?
|
Colectomy | 1 | 2023 | 696 | 0.040 |
Why?
|
Feasibility Studies | 3 | 2019 | 5306 | 0.040 |
Why?
|
Drug Monitoring | 1 | 2023 | 962 | 0.040 |
Why?
|
Treatment Failure | 1 | 2024 | 2659 | 0.040 |
Why?
|
Proctitis | 1 | 1997 | 40 | 0.040 |
Why?
|
Minocycline | 1 | 1998 | 170 | 0.040 |
Why?
|
Neuroblastoma | 1 | 1986 | 1266 | 0.040 |
Why?
|
Administration, Oral | 2 | 2014 | 4019 | 0.040 |
Why?
|
Schools | 1 | 2006 | 1496 | 0.040 |
Why?
|
Canada | 3 | 2007 | 2126 | 0.030 |
Why?
|
Cerebral Palsy | 1 | 2001 | 480 | 0.030 |
Why?
|
Interleukin-10 Receptor alpha Subunit | 1 | 2016 | 28 | 0.030 |
Why?
|
Deglutition Disorders | 1 | 2003 | 640 | 0.030 |
Why?
|
Hepatitis, Autoimmune | 1 | 1998 | 173 | 0.030 |
Why?
|
Students | 1 | 2006 | 1741 | 0.030 |
Why?
|
Dextran Sulfate | 1 | 2017 | 256 | 0.030 |
Why?
|
Radiography | 1 | 2007 | 6968 | 0.030 |
Why?
|
Sigmoidoscopy | 1 | 1996 | 150 | 0.030 |
Why?
|
Caspase 8 | 1 | 2016 | 198 | 0.030 |
Why?
|
Gastroesophageal Reflux | 2 | 2000 | 834 | 0.030 |
Why?
|
Ulcer | 1 | 1997 | 203 | 0.030 |
Why?
|
Interleukins | 1 | 2001 | 796 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2018 | 751 | 0.030 |
Why?
|
Physician Assistants | 1 | 2018 | 190 | 0.030 |
Why?
|
Body Height | 2 | 2014 | 1562 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2001 | 871 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2001 | 1241 | 0.030 |
Why?
|
Sucrase | 1 | 2015 | 51 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2018 | 36570 | 0.030 |
Why?
|
Neural Conduction | 1 | 2016 | 442 | 0.030 |
Why?
|
Endoscopy, Digestive System | 2 | 2011 | 358 | 0.030 |
Why?
|
Cognition | 1 | 2012 | 7057 | 0.030 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2016 | 299 | 0.030 |
Why?
|
Middle Aged | 11 | 2024 | 223267 | 0.030 |
Why?
|
Nurse Practitioners | 1 | 2018 | 270 | 0.030 |
Why?
|
Demography | 2 | 2012 | 1641 | 0.030 |
Why?
|
Vitamin A | 1 | 1998 | 611 | 0.030 |
Why?
|
Genotype | 2 | 2015 | 13036 | 0.030 |
Why?
|
Developmental Disabilities | 1 | 2023 | 1519 | 0.030 |
Why?
|
Solubility | 1 | 1996 | 1078 | 0.030 |
Why?
|
Comorbidity | 3 | 2015 | 10580 | 0.030 |
Why?
|
Hospitalization | 4 | 2018 | 10816 | 0.030 |
Why?
|
Depressive Disorder, Major | 2 | 2012 | 4810 | 0.030 |
Why?
|
DNA | 1 | 2007 | 7210 | 0.030 |
Why?
|
Hematoma | 1 | 1998 | 766 | 0.030 |
Why?
|
Antibodies, Anticardiolipin | 1 | 2013 | 62 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 4780 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2004 | 2678 | 0.030 |
Why?
|
Databases, Factual | 3 | 2018 | 8065 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2001 | 1368 | 0.030 |
Why?
|
Vitamin E | 1 | 1998 | 872 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2014 | 684 | 0.030 |
Why?
|
Neodymium | 1 | 2012 | 20 | 0.030 |
Why?
|
Adaptation, Psychological | 2 | 2015 | 2662 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 1998 | 2234 | 0.030 |
Why?
|
Quality Improvement | 2 | 2018 | 3850 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2009 | 2921 | 0.030 |
Why?
|
Diagnosis, Differential | 4 | 2012 | 12985 | 0.030 |
Why?
|
Genes, rRNA | 1 | 2012 | 73 | 0.030 |
Why?
|
Escherichia coli | 1 | 2004 | 4211 | 0.020 |
Why?
|
Ileal Diseases | 1 | 2012 | 70 | 0.020 |
Why?
|
Animals | 4 | 2017 | 168939 | 0.020 |
Why?
|
Needs Assessment | 1 | 2018 | 1140 | 0.020 |
Why?
|
Software Design | 1 | 2012 | 173 | 0.020 |
Why?
|
Drug Approval | 1 | 2019 | 820 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1791 | 0.020 |
Why?
|
Software | 2 | 2018 | 4464 | 0.020 |
Why?
|
Physicians, Primary Care | 1 | 2018 | 622 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2017 | 14473 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1998 | 1126 | 0.020 |
Why?
|
Inflammasomes | 1 | 2016 | 541 | 0.020 |
Why?
|
Factor VIII | 1 | 2013 | 349 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 18986 | 0.020 |
Why?
|
Psychometrics | 2 | 2012 | 3060 | 0.020 |
Why?
|
Atrophy | 1 | 1996 | 1631 | 0.020 |
Why?
|
Carbohydrate Metabolism | 1 | 2012 | 261 | 0.020 |
Why?
|
Internal-External Control | 1 | 2012 | 348 | 0.020 |
Why?
|
Catheters, Indwelling | 1 | 2013 | 436 | 0.020 |
Why?
|
Contraceptives, Oral | 1 | 2013 | 559 | 0.020 |
Why?
|
Sex Factors | 2 | 2022 | 10619 | 0.020 |
Why?
|
Risk Assessment | 2 | 2010 | 24299 | 0.020 |
Why?
|
Child Health Services | 1 | 2016 | 645 | 0.020 |
Why?
|
Colonic Diseases | 1 | 2012 | 204 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 1852 | 0.020 |
Why?
|
Maximum Tolerated Dose | 1 | 2013 | 896 | 0.020 |
Why?
|
Thrombophilia | 1 | 2013 | 308 | 0.020 |
Why?
|
Diffusion | 1 | 2012 | 808 | 0.020 |
Why?
|
Longitudinal Studies | 3 | 2016 | 14762 | 0.020 |
Why?
|
Women | 1 | 2012 | 225 | 0.020 |
Why?
|
Esophagoscopy | 1 | 1992 | 398 | 0.020 |
Why?
|
Interleukin-17 | 1 | 2016 | 923 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2016 | 2001 | 0.020 |
Why?
|
Leptin | 1 | 1998 | 1596 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2024 | 12536 | 0.020 |
Why?
|
Hypersensitivity | 1 | 1999 | 1168 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2020 | 5890 | 0.020 |
Why?
|
Biodiversity | 1 | 2012 | 345 | 0.020 |
Why?
|
Pedigree | 1 | 2017 | 4539 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 2016 | 2093 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2002 | 3485 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 8928 | 0.020 |
Why?
|
Caregivers | 1 | 2021 | 2303 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 1992 | 1104 | 0.020 |
Why?
|
Child Development | 2 | 2014 | 2327 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2016 | 2215 | 0.020 |
Why?
|
RNA | 1 | 2018 | 2715 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2014 | 811 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 1997 | 3738 | 0.020 |
Why?
|
NF-kappa B | 1 | 2017 | 2493 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2535 | 0.020 |
Why?
|
Mutation | 2 | 2016 | 30214 | 0.020 |
Why?
|
Metagenomics | 1 | 2012 | 473 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 2006 | 4853 | 0.020 |
Why?
|
Defecation | 1 | 2009 | 190 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2016 | 3157 | 0.020 |
Why?
|
Catheterization | 1 | 2013 | 1429 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2001 | 3079 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2533 | 0.020 |
Why?
|
Research Design | 2 | 2019 | 6206 | 0.020 |
Why?
|
Biological Transport | 1 | 2012 | 2083 | 0.020 |
Why?
|
Sexual Maturation | 1 | 2009 | 256 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2016 | 2429 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10745 | 0.020 |
Why?
|
Propensity Score | 1 | 2014 | 1972 | 0.020 |
Why?
|
Antirheumatic Agents | 1 | 2016 | 1383 | 0.020 |
Why?
|
Fibroblasts | 1 | 2017 | 4166 | 0.020 |
Why?
|
Acute Disease | 2 | 2011 | 7240 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 1997 | 5502 | 0.020 |
Why?
|
Prednisolone | 1 | 2007 | 326 | 0.020 |
Why?
|
Base Sequence | 1 | 2017 | 12415 | 0.020 |
Why?
|
Thinness | 1 | 2009 | 482 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7585 | 0.020 |
Why?
|
Amino Acids | 1 | 2012 | 1711 | 0.020 |
Why?
|
Ganglioneuroma | 1 | 1986 | 53 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 2350 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3360 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2012 | 1409 | 0.020 |
Why?
|
Genome, Human | 1 | 2018 | 4443 | 0.020 |
Why?
|
Myoclonus | 1 | 1986 | 107 | 0.020 |
Why?
|
Eosinophilia | 2 | 2000 | 554 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 18076 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4047 | 0.020 |
Why?
|
Social Support | 1 | 2015 | 2191 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2015 | 6020 | 0.010 |
Why?
|
Radiology | 1 | 2018 | 2105 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1889 | 0.010 |
Why?
|
Urography | 1 | 1986 | 316 | 0.010 |
Why?
|
Affect | 1 | 2012 | 1494 | 0.010 |
Why?
|
Aged | 5 | 2024 | 171344 | 0.010 |
Why?
|
Phylogeny | 1 | 2012 | 2840 | 0.010 |
Why?
|
Abdominal Neoplasms | 1 | 1986 | 286 | 0.010 |
Why?
|
Cyclosporine | 1 | 2007 | 778 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 4410 | 0.010 |
Why?
|
Pelvic Neoplasms | 1 | 1986 | 249 | 0.010 |
Why?
|
Signal Transduction | 2 | 2017 | 23618 | 0.010 |
Why?
|
Alleles | 1 | 2015 | 6896 | 0.010 |
Why?
|
Heparin | 1 | 2011 | 1636 | 0.010 |
Why?
|
Thoracic Neoplasms | 1 | 1986 | 269 | 0.010 |
Why?
|
Insurance, Health | 1 | 2015 | 2520 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2012 | 2429 | 0.010 |
Why?
|
Chemoprevention | 1 | 2005 | 327 | 0.010 |
Why?
|
Immune System Diseases | 1 | 2005 | 253 | 0.010 |
Why?
|
Weight Loss | 1 | 2014 | 2712 | 0.010 |
Why?
|
Diarrhea, Infantile | 1 | 2002 | 100 | 0.010 |
Why?
|
Eye Movements | 1 | 1986 | 510 | 0.010 |
Why?
|
Motivation | 1 | 2012 | 2020 | 0.010 |
Why?
|
Pain Measurement | 1 | 2012 | 3576 | 0.010 |
Why?
|
Health Surveys | 1 | 2012 | 4055 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5873 | 0.010 |
Why?
|
Ascorbic Acid Deficiency | 1 | 2001 | 26 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2017 | 10451 | 0.010 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2002 | 187 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1986 | 1986 | 0.010 |
Why?
|
Macrophages | 1 | 2016 | 5784 | 0.010 |
Why?
|
Hemorrhage | 1 | 2013 | 3464 | 0.010 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2007 | 1988 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2012 | 3139 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2012 | 3563 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2012 | 2085 | 0.010 |
Why?
|
Postoperative Period | 1 | 2005 | 1824 | 0.010 |
Why?
|
Nutritional Requirements | 1 | 2001 | 276 | 0.010 |
Why?
|
Gastrostomy | 1 | 2003 | 325 | 0.010 |
Why?
|
Interleukin-15 | 1 | 2001 | 186 | 0.010 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2002 | 292 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2003 | 913 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2012 | 7119 | 0.010 |
Why?
|
Steroids | 1 | 2004 | 936 | 0.010 |
Why?
|
Recovery of Function | 1 | 2009 | 2978 | 0.010 |
Why?
|
Rectum | 1 | 2004 | 897 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6514 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11924 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3530 | 0.010 |
Why?
|
Models, Statistical | 1 | 2012 | 5092 | 0.010 |
Why?
|
Zinc | 1 | 2001 | 675 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7870 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2001 | 1251 | 0.010 |
Why?
|
Brain Diseases | 1 | 1986 | 1552 | 0.010 |
Why?
|
Tuberculosis | 1 | 2009 | 2011 | 0.010 |
Why?
|
Overweight | 1 | 2007 | 2447 | 0.010 |
Why?
|
Palliative Care | 1 | 2011 | 3640 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 16044 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2005 | 6853 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2009 | 4306 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1999 | 2478 | 0.010 |
Why?
|
HIV Infections | 1 | 2001 | 17532 | 0.010 |
Why?
|
Eosinophils | 1 | 1999 | 952 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2004 | 2645 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 1986 | 2561 | 0.010 |
Why?
|
Acne Vulgaris | 1 | 1998 | 352 | 0.010 |
Why?
|
Esophagus | 1 | 1999 | 1040 | 0.010 |
Why?
|
Ultrasonography | 1 | 1986 | 5990 | 0.010 |
Why?
|
Cytokines | 1 | 2006 | 7438 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 1986 | 2930 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 1999 | 1794 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 1986 | 11218 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 1986 | 4356 | 0.010 |
Why?
|
Mice | 1 | 2016 | 81898 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 1998 | 20710 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2001 | 3853 | 0.000 |
Why?
|
Survival Analysis | 1 | 2001 | 10101 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1986 | 9407 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2002 | 10384 | 0.000 |
Why?
|
Brain Neoplasms | 1 | 1986 | 9101 | 0.000 |
Why?
|
Neprilysin | 1 | 1985 | 487 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1986 | 13489 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2003 | 59548 | 0.000 |
Why?
|
Antigens, Neoplasm | 1 | 1985 | 1998 | 0.000 |
Why?
|
B-Lymphocytes | 1 | 1985 | 4787 | 0.000 |
Why?
|